🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Few recent RadOnc factoids‼️ 1.👍🏼👍🏼Fulfillment 2.👍🏼👍🏼Work hours 3.👍🏼👍🏼Compensation But… 4.👎🏼👎🏼Job market No surprise RadOnc was once a top 5 most competitive field. I find my work incredibly rewarding!Congrats to those joining the field! But WE have work to do‼️

Women should get screened for breast cancer every other year starting at age 40, according to new USPSTF guidelines. Our Dr. Therese Bevers weighs in: brnw.ch/21wJkfX TODAY #BreastCancer #EndCancer

Thank you Grey's Anatomy for highlighting our COSINR trial at UChicagoCancerCenter University of Chicago Radiation Oncology for cytoreductive ablative radiotherapy and immunotherapy for first-line metastatic NSCLC.

Diary of a Rad Onc Resident. Just came across this tongue-in-cheek 'typical' day in #radonc ! Made me actually laugh out loud! Found it on Reddit.

🚀 Excited to share our latest research! We developed GRITIC, a novel method for timing genomic gains using bulk WGS data. Our findings reveal non-parsimonious evolution and increased chromosomal instability post-genome doubling in tumors. aacrjournals.org/cancerdiscover… #cancergenomics

Hot off the press in IJROBP - The Red Journal: the ARREST phase I trial of SABR in poly-metastatic disease, led by Glenn Bauman, MD & Tim Nguyen Average number of lesions = 16 Dose safely escalated to 30 Gy in 5 fractions. sciencedirect.com/science/articl… The phase II/III RCT ARREST2 is underway!

A teaching case from UCLA reports the effectiveness of a single fraction of 1 Gy in saving the life of an intubated patient with Diffuse Alveolar Hemorrhage secondary to Extramedullary Hematopoiesis. #radonc advancesradonc.org/article/S2452-…

Great to be home in #radonc. For first day back, we present 50Gy/1fx to bilateral L2, L3, L4 sensory nerve roots for intractable spasticity on the Varian sponsored SPASM trial Thanks to my rad onc & physics colleagues and exceptional team at OhioStateRadOnc for helping

Congrats Ethan Ludmir MD and Chad Tang, MD! This MD Anderson Cancer Center P2 randomized study shows PFS of 10.3 mo vs. 2.5 mo in #PancreasCancer pts with oligometastatic dz treated with metastasis-directed therapy+sys tx vs. sys tx alone. #radonc #endcancer ascopubs.org/doi/10.1200/JC…

Just published in Annals of Oncology ESMO - Eur. Oncology our paper on intrapatient variation in PD-L1 and TMB in #NSCLC authors.elsevier.com/c/1jZPc3I2OQih… Jim Smithy Biagio Ricciuti, MD PhD João Alessi, MD Federica Pecci Mark Awad

Check out the new study from Sean Pitroda, M.D. and I, providing further validation for aneuploidy as a predictive and prognostic biomarker following immunotherapy in patients with non-small cell lung cancer! nature.com/articles/s4159…

Single fraction RT (8Gy) significantly improves hepatic pain compared with best supportive care and can be considered standard palliative treatment. No increase in toxicity. Laura Dawson CCTG thelancet.com/journals/lanon…